| P50 | author | Parthasarathy Seshacharyulu | Q51138077 |
| | Imayavaramban Lakshmanan | Q59681803 |
| | Sidharth Mahapatra | Q59756613 |
| P2093 | author name string | Surinder K Batra | |
| | Moorthy P Ponnusamy | |
| | Seema Chugh | |
| | Arokia P Vaz | |
| | Saswati Karmakar | |
| | Yuri M Sheinin | |
| P2860 | cites work | Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4 | Q22008002 |
| | Human RNA polymerase II-association factor 1 (hPaf1/PD2) regulates histone methylation and chromatin remodeling in pancreatic cancer | Q24295252 |
| | The human PAF complex coordinates transcription with events downstream of RNA synthesis | Q24307917 |
| | A genome-scale RNAi screen for Oct4 modulators defines a role of the Paf1 complex for embryonic stem cell identity | Q24312181 |
| | Histone H2B monoubiquitination functions cooperatively with FACT to regulate elongation by RNA polymerase II | Q24337471 |
| | Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment | Q24656967 |
| | Sox2 and Oct-3/4: a versatile pair of master regulators that orchestrate the self-renewal and pluripotency of embryonic stem cells | Q24657573 |
| | 19q13 amplification is associated with high grade and stage in pancreatic cancer | Q40045624 |
| | The human homologue of the RNA polymerase II-associated factor 1 (hPaf1), localized on the 19q13 amplicon, is associated with tumorigenesis. | Q40313636 |
| | Cancer of the ovary, fallopian tube, and peritoneum | Q41266914 |
| | DCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancer | Q41906889 |
| | CD44 is of Functional Importance for Colorectal Cancer Stem Cells | Q58022858 |
| | Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells | Q64376527 |
| | Oct-3/4 is a dose-dependent oncogenic fate determinant | Q79358420 |
| | CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification | Q83955619 |
| | Development and applications of CRISPR-Cas9 for genome engineering | Q28241526 |
| | Asymmetric and symmetric stem-cell divisions in development and cancer | Q28249478 |
| | Cancer stem cells in solid tumours: accumulating evidence and unresolved questions | Q28293535 |
| | Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells | Q28473082 |
| | Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells | Q28590205 |
| | CRISPR-Cas systems for editing, regulating and targeting genomes | Q29615781 |
| | Tumour stem cells and drug resistance | Q29617742 |
| | Inhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides | Q30478184 |
| | The human RNA polymerase II-associated factor 1 (hPaf1): a new regulator of cell-cycle progression | Q33505663 |
| | The role of cancer stem cells and the side population in epithelial ovarian cancer | Q33516247 |
| | Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant | Q33547790 |
| | RNA polymerase II associated factor 1/PD2 maintains self-renewal by its interaction with Oct3/4 in mouse embryonic stem cells | Q33937012 |
| | Novel role of pancreatic differentiation 2 in facilitating self-renewal and drug resistance of pancreatic cancer stem cells | Q33994268 |
| | CRISPR/Cas9-mediated gene knock-down in post-mitotic neurons | Q34070995 |
| | PD2/Paf1 depletion in pancreatic acinar cells promotes acinar-to-ductal metaplasia | Q34101017 |
| | Cancer stem cells: an old idea--a paradigm shift | Q34495973 |
| | Ovarian cancer stem cell-like side populations are enriched following chemotherapy and overexpress EZH2. | Q34569371 |
| | Part I: chemotherapy for epithelial ovarian cancer-treatment at first diagnosis | Q34826546 |
| | Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells | Q35190005 |
| | Ovarian cancer stem cell markers: prognostic and therapeutic implications | Q35606242 |
| | A concise review on the current understanding of pancreatic cancer stem cells | Q35801362 |
| | Ovarian cancer metastasis: integrating insights from disparate model organisms | Q36111930 |
| | ZIC2-dependent OCT4 activation drives self-renewal of human liver cancer stem cells | Q36165630 |
| | PAF1, a Molecular Regulator of Promoter-Proximal Pausing by RNA Polymerase II | Q36371761 |
| | Small putative NANOG, SOX2, and SSEA-4-positive stem cells resembling very small embryonic-like stem cells in sections of ovarian tissue in patients with ovarian cancer | Q36651828 |
| | Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma | Q36772125 |
| | Human RNA polymerase II-associated factor complex: dysregulation in cancer. | Q36864019 |
| | Impaired expression of protein phosphatase 2A subunits enhances metastatic potential of human prostate cancer cells through activation of AKT pathway. | Q36959063 |
| | Ovarian cancer: emerging concept on cancer stem cells | Q36975266 |
| | Cancer stem cells and therapeutic targets: an emerging field for cancer treatment | Q37200395 |
| | EZH2 promotes colorectal cancer stem-like cell expansion by activating p21cip1-Wnt/β-catenin signaling | Q37520284 |
| | Prominin-1 (CD133) Expression in the Prostate and Prostate Cancer: A Marker for Quiescent Stem Cells. | Q38060596 |
| | RNA polymerase II-associated factor 1 regulates the release and phosphorylation of paused RNA polymerase II. | Q38812273 |
| | Apigenin inhibits the self-renewal capacity of human ovarian cancer SKOV3‑derived sphere-forming cells | Q38939676 |
| | Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer | Q39041030 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| | neoplastic stem cells | Q1638475 |
| P304 | page(s) | 14806-14820 | |
| P577 | publication date | 2017-02-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | hPaf1/PD2 interacts with OCT3/4 to promote self-renewal of ovarian cancer stem cells | |
| P478 | volume | 8 | |